Empire Genomics' Convertible Note - II Round

Empire Genomics raised a round of funding on November 19, 2014. Investors include Rand Capital.

Empire Genomics (EG) is a molecular diagnostics company that develops and offers a comprehensive menu of assay services for use in diagnosing and guiding precise therapeutic treatments for patients, b…

Articles about Empire Genomics' Convertible Note - II Round: